Guidance for COVID-19 Prevention and Control in Schools. Arabic Version
The purpose of this document is to provide clear and actionable guidance for safe operations through the prevention, early detection and control of COVID-19 in schools and other educational facilities. The guidance, while speci...fic to countries that have already confirmed the transmission of COVID-19, is relevant in all other contexts. Education can encourage students to become advocates for disease prevention and control at home, in school and in their community by talking to others about how to prevent the spread of viruses. Maintaining safe school operations or reopening schools after a closure requires many considerations but, if done well, can promote public health
more
Participants’ Evaluation | COVID-19 TTX
Your feedback will assist us to maintain and improve the quality and relevance of future simulation exercises.
Deployment of Residents in Various Facilities Designated for Screening and Management of Patients with COVID-19 and the non covid area of the hospital (in this SOP, the term “resident” includes DNB and CPS students)
Elderly people are at a higher risk of COVID-19 infection due to their decreased immunity and body reserves, as well as multiple associated comorbidities like diabetes, hypertension, chronic kidney disease and chronic obstructive pulmonary disease. Also, course of disease tends to be more severe in ...case of elderlies resulting in higher mortality.
more
Date : 15.07.2015
Test enzymatique sur bandelettes pour le dosage semi-quantitatif de l’H2O2
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...a evaluado la eficacia).Entre los participantes sin evidencia de infección previa por SARS-CoV-2, hubo 3 casos de COVID-19 entre los 1.305 receptores de vacuna a partir de los 7 días de la segunda dosis y 16 entre los 663 receptores de placebo.
more
During the COVID-19 outbreak all of us should take some extra time and care for ourselves. Follow some simple strategies to improve your well-being.
Data ultimo aggiornamento: 23 marzo 2020
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
Временные рекомендации
4 марта 2020 г.
Данный инструмент предназначен для лечебных учреждений, в которых осуществлялся уход за пациентами с COVID-19 или в которые пос...упали такие пациенты. Данный бланк надлежит заполнить всем медицинским работникам, контактировавшим с пациентом с подтвержденным диагнозом COVID-19 в лечебном учреждении. Он призван служить оперативным инструментом для лечебных учреждений после выявления в учреждении пациента с COVID-19. Этот инструмент позволит определить риск инфицирования вирусом COVID-19 для всех медицинских работников (МР), контактировавших с пациентом с COVID-19, и дать рекомендации по ведению этих МР с учетом риска их заражения.
more
Die folgenden Empfehlungen sind als Unterstützung und Anregung gedacht, die stets individuell angepasst undabgewandelt werden können. Sie basieren auf unserem Wissensstand vom 18.03.2020.